Clarice P Lin is a Chicago, Illinois based female rheumatologist who is specialized in Rheumatology. Active license number of Clarice P Lin for Rheumatology is 125.082692 in Illinois. Clarice P Lin treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Clarice P Lin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
675 N Saint Clair St Ste 14-100, Chicago, Illinois, 60611-5966
Phone:
312-695-8628
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1669051777
NPI Enumeration Date:
06 Apr, 2021
NPI Last Update On:
20 Oct, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Clarice P Lin are as mentioned below.
License Number
Specialization
State
Status
125.082692
Rheumatologist
Illinois
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
675 N Saint Clair St Ste 14-100, Chicago, Illinois
Zip:
60611-5966
Phone Number:
312-695-8628
Fax Number:
--
Patients can reach Clarice P Lin at 675 N Saint Clair St Ste 14-100, Chicago, Illinois or can call to book an appointment on 312-695-8628. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.